DocGo Inc. (NASDAQ:DCGO – Get Free Report) was the recipient of a large growth in short interest in February. As of February 28th, there was short interest totalling 7,710,000 shares, a growth of 17.5% from the February 13th total of 6,560,000 shares. Currently, 8.8% of the company’s shares are sold short. Based on an average daily trading volume, of 759,000 shares, the short-interest ratio is presently 10.2 days.
Analyst Upgrades and Downgrades
A number of research firms recently commented on DCGO. Deutsche Bank Aktiengesellschaft lowered DocGo from a “buy” rating to a “hold” rating and lowered their price target for the company from $5.00 to $2.85 in a research report on Friday, February 28th. Stifel Nicolaus cut their price target on DocGo from $6.50 to $5.50 and set a “buy” rating for the company in a research note on Friday, February 28th. Finally, Needham & Company LLC cut their target price on DocGo from $7.00 to $4.00 and set a “buy” rating for the company in a research note on Friday, February 28th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $4.89.
Read Our Latest Stock Analysis on DocGo
Institutional Investors Weigh In On DocGo
DocGo Stock Performance
DocGo stock opened at $2.76 on Friday. The stock has a fifty day moving average of $4.20 and a 200 day moving average of $3.95. DocGo has a one year low of $2.73 and a one year high of $5.68. The stock has a market cap of $281.47 million, a PE ratio of 9.86, a price-to-earnings-growth ratio of 14.16 and a beta of 1.08.
DocGo Company Profile
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
See Also
- Five stocks we like better than DocGo
- What Does Downgrade Mean in Investing?
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- Differences Between Momentum Investing and Long Term Investing
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.